Question

write a financial statement for "ALEMBIC PHARMACEUTICALS"

Answer 1

ALEMBIC PHARMACEUTICALS

A)

Balance Sheet as at 31st March, 2019 As at 31st March, 2019 As at 31st March, 2018 $ $ 900 1,000 1,100 10 750 500 300 20 50 Particulars ASSETS (1) Non-Current Assets (a) Property, Plant and Equipment (b) Capital work-in-progress (c) Investment Property (d) Financial Assets: (i) Investments (e) Other Non-Current Assets - Capital Adv nce (2) Current Assets (a) Inventories (b) Financial Assets (i) Trade receivables (ii) Cash and cash equivalents (iii) Bank balances other than cash and cash equivalents (iv) Others financial assets (c) Current Tax Assets (Net) (d) Other current assets 900 700 550 600 150 10 5 5 10 50 5 5 250 350 TOTAL ASSETS 4500 3720 50 50 2600 2150 450 500 EQUITY AND LIABILITIES EQUITY (a) Equity Share capital (b) Other Equity LIABILITIES (1) Non-Current Liabilities (a) Financial Liabilities (i) Borrowings (b) Provisions (c) Deferred tax liabilities (Net) (2) Current liabilities (a) Financial Liabilities (i) Borrowings (ii) Trade payables (iii) Other financial liabilities (b) Other current liabilities (c) Provisions 50 40 50 50 400 500 150 540 50 250 100 150 50 40 TOTAL EQUITY AND LIABILITIES 4500 3720

B)

Statement of Profit and Loss for the year ended 31st March, 2019 3700 3000 Particulars (1) Revenue from Operations (11) Other Income (111) Total Income 20 10 3720 3010 850 750 250 200 -50 (IV) Expenses Cost of Materials Consumed Purchase of Stock-in-Trade Changes in Inventories of Finished Goods and Work-in-Progress Employee Benefits Expense Finance costs Depreciation and amortisation expense Other Expenses Total Expense (IV) -100 700 600 20 10 100 100 850 1100 2920 2460 (V) Profit Before Tax (III-IV) 800 550 160 110 (VI) Tax Expense (i) Current Tax (ii) Short/Excess) Tax Provision (VII)Profit after Tax (V-VI) -10 -5 650 445 Earnings per equity share 26 17.8

B)

Statement of Profit and Loss for the year ended 31st March, 2019 3700 3000 Particulars (1) Revenue from Operations (11) Other Income (111) Total Income 20 10 3720 3010 850 750 250 200 -50 (IV) Expenses Cost of Materials Consumed Purchase of Stock-in-Trade Changes in Inventories of Finished Goods and Work-in-Progress Employee Benefits Expense Finance costs Depreciation and amortisation expense Other Expenses Total Expense (IV) -100 700 600 20 10 100 100 850 1100 2920 2460 (V) Profit Before Tax (III-IV) 800 550 160 110 (VI) Tax Expense (i) Current Tax (ii) Short/Excess) Tax Provision (VII)Profit after Tax (V-VI) -10 -5 650 445 Earnings per equity share 26 17.8

Summary of Financial Statement

Income Statement

• Revenue from operation increased from 3000 to 3700
• Total expence also increased
• Profit available to the Equity share holders increased from 445 to 650

Balance Sheet

• Owners equity increased from 2200 to 2650
• Investment also increased from 300 to 500
• Capital Work in progress increased from 750 to 1100

Both shows an improved performance result and a better financial position